Table 2. HIV parameters of study group (n = 97).
Duration of HIV (years) | 11.1 (5.8–15.6) |
Duration of ART (years) | 7.2 (3.6–11.8) |
CD4 (cells/mm3) | 552 (434–717) |
CD4 nadir (cells/mm3) | 200 (98–260) |
ART | |
3 NRTI | 5 (5%) |
2 NRTI + 1 NNRTI | 59 (61%) |
2 NRTI + 1 PI | 26 (27%) |
1 NNRTI + 1 PI | 7 (7%) |
Fully suppressed HIV RNA* | 96/97 (99%)** |
Values are median (interquartile range).
ART: Highly active antiretroviral therapy; NRTI: Nucleoside transcriptase inhibitor, NNRTI: Non-nucleoside transcriptase inhibitor, PI: Protease inhibitor.
*) HIV RNA≤400 copies/mL;
**) The remaining patient had viral load = 560 copies/ml.